LH - LABCORP HOLDINGS INC.


282.99
-3.480   -1.230%

Share volume: 385,349
Last Updated: 03-03-2026
Healthcare/Services – Health: -0.06%

PREVIOUS CLOSE
CHG
CHG%

$286.47
-3.48
-0.01%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Fundamental analysis
52%
Profitability 67%
Dept financing 30%
Liquidity 23%
Performance 50%
Company vs Stock growth
vs
Performance
5 Days
-2.12%
1 Month
2.47%
3 Months
8.23%
6 Months
2.82%
1 Year
10.19%
2 Year
12.27%
Key data
Stock price
$282.99
P/E Ratio 
25.33
DAY RANGE
$278.70 - $284.29
EPS 
$10.54
52 WEEK RANGE
$209.38 - $293.72
52 WEEK CHANGE
$11.29
MARKET CAP 
22.203 B
YIELD 
1.15%
SHARES OUTSTANDING 
82.400 M
DIVIDEND
$0.72
EX-DIVIDEND DATE
02-27-2025
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$574,188
AVERAGE 30 VOLUME 
$738,356
Company detail
CEO: Adam H. Schechter
Region: US
Website: labcorp.com
Employees: 75,500
IPO year: 1990
Issue type:
Market: NYSE
Industry: Healthcare/Services – Health
Sector: Services

Laboratory Corporation of America Holdings operates as an independent clinical laboratory company worldwide. It offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, and prostate-specific antigens. The company also provides specialty testing services, including gene-based and esoteric testing.

Recent news